Date

Monday, March 28, 2022

Venue

Time

10:00 (GMT+7)

Agenda

1. Approval of the change in the Board members composition.
2. The Board of Directors' report regarding the company's business activities, including the company's Financial Statements of the financial year 2020; approval of the company's Consolidated Financial Statements 2020, and the Consolidated Income statement of the financial year 2020; including the proposed refusal to to release and discharge of all responsibilities (volledig acquit et de charge) to all Board members for the management and supervision carried out in the financial year 2020.
3. Approval of the accountability of the Company's Board of Commissioners.
4. Approval of remuneration & allowances for Board of Directors and Board of Commissioners for 2022 and 2023.
5. Delegation of authority to Board of Directors to elect a Public Accountant Firm to audit the company Financial Report of the financial year 2020 and 2021, and authorise to determine the honorarium of the Public Accountant and the other requirements.
6. Approval and full authorization to Board of Directors with the rights of substitution to take legal action if the financial statements 2020 and 2021 contain material deviations by Board of Directors and/or employees during the period of material deviation transactions.
7. Reaffirmation to the Shareholders’s approval on the company's plan to issue new shares with a Debt to Equity Swap (DES) through Capital Increase without Pre-emptive Rights (PMTHMETD) in accordance to the Court Decision Number 180/PDT.SUS-PKPU/2020/PN. NIAGA.JKT.PST dated October 26, 2020.
8. Reaffirmation to the Shareholders’s approval regarding the Amendment/Adjustment to the company's Articles of Association based on POJK No. 15/POJK.04/2020 dated April 20, 2020.